Prevalence and Health System Determinants Of Uptake Of Three Or More Doses Of Sulphadoxine Pyrimethamine For Intermittent Preventive Treatment Of Malaria During Pregnancy
- PMID: 40276557
- PMCID: PMC7617606
Prevalence and Health System Determinants Of Uptake Of Three Or More Doses Of Sulphadoxine Pyrimethamine For Intermittent Preventive Treatment Of Malaria During Pregnancy
Abstract
Background: Maternal anemia, low birth weight, intrauterine growth retardation and premature births are complications associated with malaria in pregnancy (MIP). In order to prevent malaria, Wold Health Organization (WHO) recommends at least three doses of Sulphadoxine Pyrimethamine (SP) for Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp-SP3+) during the antenatal period. This study aimed to determine the prevalence and the health system determinants of uptake of three or more doses (IPTp 3+) in Busia County, Kenya.
Methods: A facility-based cross-sectional study conducted at Busia County Referral Hospital between June and July 2023. Mothers' in the Maternity Unit with term deliveries were consecutively sampled. Data on health system factors was collected using interviewer administered semi-structured questionnaires and interview guides. The statistical significance of health system factors affecting IPTp-SP3+ was dertemined using the odds ratio (OR) and adjusted OR.
Results: The prevalence of IPTp-SP 3+ uptake was 43.0%. Health system factors significantly associated with IPTp-SP 3+ uptake were facility being too far (aOR = 0.575, 95% CI: 0.351- 0.941, p = 0.028) and waiting time being too long (aOR = 0.606, 95% CI: 0.385-0.955, p = 0.031).
Conclusion: Prevalence of uptake of IPTp 3+ is still low, with less than half of the pregnant mothers complying. The County and National Ministries of Health should make a concerted effort to ensure availability and affordability of SP drugs and also ensure access to and customer satisfaction at the healthcare facilities.
Figures
Similar articles
-
Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.Infect Dis Poverty. 2021 Aug 6;10(1):106. doi: 10.1186/s40249-021-00887-4. Infect Dis Poverty. 2021. PMID: 34362443 Free PMC article.
-
Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.BMC Pregnancy Childbirth. 2019 Jul 8;19(1):236. doi: 10.1186/s12884-019-2397-1. BMC Pregnancy Childbirth. 2019. PMID: 31286878 Free PMC article.
-
Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.BMC Pregnancy Childbirth. 2018 Apr 20;18(1):108. doi: 10.1186/s12884-018-1744-y. BMC Pregnancy Childbirth. 2018. PMID: 29678150 Free PMC article.
-
Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.Malar J. 2024 Jan 4;23(1):6. doi: 10.1186/s12936-023-04816-8. Malar J. 2024. PMID: 38178125 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
References
-
- World Health Organization. World Malaria Report. 2021. [accessed: 22/6/2022]. https://www.who.int/teams/global-malaria-programme/reports/world-malaria... .
-
- Kenya Malaria Indicator Survey. Kenya Malaria Indicator Survey. 2015. https://dhsprogram.com/pubs/pdf/MIS22/MIS22.pdf 22/6/2022.
-
- Wanyonyi WA, Mulambalah CS, Mulama DH, Omukunda E. Malaria prevalence and risk analysis among pregnant women in Bungoma county, Kenya. Med Sci. 2019;8(2):301–6. [Internet] Available from: www.medicinescience.org.
-
- Guyatt HL, Snow RW. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001;95(6):569–76. [Internet] - PubMed
-
- Nyamu GW, Kihara JH, Oyugi EO, Omballa V, El-Busaidy H, Jeza VT. Prevalence and risk factors associated with asymptomatic Plasmodium falciparum infection and anemia among pregnant women at the first antenatal care visit: A hospital based cross-sectional study in Kwale County, Kenya. PLoS One. 2020;15(10):e0239578. doi: 10.1371/journal.pone.0239578. [Internet] Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239578. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources